Compounds
The present invention relates to therapeutically active xanthine derivative compounds of Formula (I): corresponding processes for manufacture of said derivatives, pharmaceutical formulations containing and uses of such compounds in therapy, particularly in treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.
1. A method for treatment of type II diabetes mellitus comprising administering to a subject in need thereof a therapeutically effective amount of a compound which is 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione
a pharmaceutically acceptable salt thereof.
2. The method for treatment of type II diabetes mellitus according to claim 1 , wherein the subject is a human.